Composition for therapeutic use, including an organic lipid phase and a rare- earth radioisotope complex

The invention relates to a therapeutic compn. including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an org. lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone.

Data and Resources

Composition for therapeutic use, including an...HTML
Explore
- More information
- Go to resource

Additional Info

Field	Value
Source	https://hal.science/hal-00936709
Author	Lepareur, Nicolas, Garin, Etienne, Noiret, Nicolas, Ardisson, Valérie
Maintainer	CCSD
Last Updated	May 7, 2026, 06:10 (UTC)
Created	May 7, 2026, 06:10 (UTC)
Identifier	Patent N°: WO 2014012997
Language	en
contributor	Microenvironnement et remodelage ; Foie, métabolismes et cancer ; Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes (Biosit : Biologie - Santé - Innovation Technologique)-Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes (Biosit : Biologie - Santé - Innovation Technologique)-Université européenne de Bretagne - European University of Brittany (UEB)
creator	Lepareur, Nicolas
date	2014-01-23T00:00:00
metadata_modified	2025-07-01T00:00:00
set_spec	type:PATENT